Safety and Immunogenicity of COVID-19 Vaccination in NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of COVID-19 Vaccination in Patients With Non-Alcoholic Fatty Liver Disease (CHESS2101): A Multicenter Study
J. Hepatol. 2021 Apr 24;[EPub Ahead of Print], J Wang, Z Hou, J Liu, Y Gu, Y Wu, Z Chen, J Ji, S Diao, Y Qiu, S Zou, A Zhang, N Zhang, F Wang, X Li, Y Wang, X Liu, C Lv, S Chen, D Liu, X Ji, C Liu, T Ren, J Sun, Z Zhao, F Wu, F Li, R Wang, Y Yan, S Zhang, G Ge, J Shao, S Yang, C Liu, Y Huang, D Xu, X Li, J Ai, Q He, MH Zheng, L Zhang, Q Xie, DC Rockey, JA Fallowfield, W Zhang, X QiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.